Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.

This report studies the eosinophilic esophagitis drug market.
AstraZeneca, GSK and Bayer are the leading producers of eosinophilic esophagitis drug, which together account for about 80% of the market.
North America is the leading region, accounting for more than 30% of the market, followed by Europe at nearly 30%.

Market Analysis and Insights: Global Eosinophilic Esophagitis Drug Market
In 2020, the global Eosinophilic Esophagitis Drug market size was US$ 123 million and it is expected to reach US$ 178.9 million by the end of 2027, with a CAGR of 5.5% during 2021-2027.
Global Eosinophilic Esophagitis Drug Scope and Market Size
Eosinophilic Esophagitis Drug market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Eosinophilic Esophagitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Eosinophilic Esophagitis Drug market is segmented into
Budesonide
Fluticasone
Others

Segment by Application, the Eosinophilic Esophagitis Drug market is segmented into
Hospitals
Clinics
Drugstore

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and Eosinophilic Esophagitis Drug Market Share Analysis
Eosinophilic Esophagitis Drug market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Eosinophilic Esophagitis Drug product introduction, recent developments, Eosinophilic Esophagitis Drug sales by region, type, application and by sales channel.

The major companies include:
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Takeda
Calypso
Celgene
Regeneron